Earendil Labs
Data as of .
Company facts
-
Founded
2021
-
Headquarters
United States (affiliate Helixon in China)
Latest funding round
- Round
- Financing
- Date
- Mar 2026
- Amount
- $787M
Drug discovery partners
3 pharma, 1 other. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
Genentech (Roche) Pharma
Research collaboration,
$55M upfront ($1.5B total potential)
-
Sanofi Pharma
Discovery collaboration,
$160M upfront ($2.56B total potential)
-
Sanofi Pharma
Asset license (HXN-1002, HXN-1003),
$125M upfront ($1.84B total potential)
-
WuXi XDC CRO
ADC payload technology collaboration,
Terms not disclosed
Recent news
-
Research collaboration with Genentech (Roche) ($55M upfront ($1.5B total potential))
-
Announces $787M in financing to scale AI-driven biologics discovery
-
WuXi XDC strategic collaboration
-
Discovery collaboration with Sanofi ($160M upfront ($2.56B total potential))
-
Asset license (HXN-1002, HXN-1003) with Sanofi ($125M upfront ($1.84B total potential))
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.